KORU Medical Systems Prepares to Share Q3 2024 Financial Results
KORU Medical Systems (NASDAQ: KRMD) is making headlines as it gears up to report its financial results for the third quarter of 2024. This announcement is expected to provide valuable insights into the company’s performance and strategic initiatives aimed at enhancing patient care through innovative medical technologies.
Company Overview
As a leading player in the medical technology sector, KORU Medical focuses on developing, manufacturing, and commercializing large volume subcutaneous infusion solutions. These patient-centric products are designed to improve the quality of life for individuals who require frequent medication administration, whether from home or in medical facilities.
Innovative Infusion Solutions
KORU Medical’s flagship offerings include the FREEDOM Syringe Infusion System. This system consists of devices such as the FREEDOM60 and FreedomEdge Syringe Infusion Drivers, along with Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These products have been instrumental in self-administration of medication, empowering patients to manage their treatment effectively.
Commitment to Patient Care
The company’s dedication to patient care is reflected in its continuous efforts to innovate and adapt its technologies. The FREEDOM Syringe Infusion System has been in the market since 1994, receiving FDA clearance for its safety and efficacy. This long-standing presence demonstrates KORU Medical’s commitment to providing advanced solutions that meet the growing needs of patients and healthcare professionals alike.
Upcoming Conference Call Details
On reporting day, KORU Medical’s management will hold a conference call at 4:30 p.m. ET to discuss these financial results in detail. Participants in the U.S. can join by dialing (877)-407-0784, while international attendees can connect at (201)-689-8560. This session will give stakeholders an opportunity to gain a deeper understanding of the company’s performance and future direction.
About KORU Medical Systems
KORU Medical Systems is at the forefront of innovation in medical technology, focusing on solutions that facilitate the effective administration of therapies to patients. With a strong portfolio that serves both patients and healthcare providers, the company aims to streamline and enhance the infusion process, ensuring greater patient safety and comfort.
Additionally, KORU Medical supports biopharmaceutical companies by providing products that are vital for clinical trials and drug development, showcasing its versatility and adaptability in the dynamic healthcare landscape.
Frequently Asked Questions
What is the significance of KORU Medical's upcoming financial results report?
The report will provide insights into the company’s financial health, operational strategies, and future market outlook, essential for stakeholders and investors.
How can I participate in the conference call?
You can join the conference call by dialing (877)-407-0784 for U.S. participants or (201)-689-8560 for international attendees.
What products does KORU Medical specialize in?
KORU Medical specializes in large volume subcutaneous infusion solutions, primarily through the FREEDOM Syringe Infusion System, enhancing patient care and medication delivery.
When will the financial results be announced?
The financial results for the third quarter of 2024 will be reported on November 13, 2024.
Where can I find more information about KORU Medical's products?
You can learn more about KORU Medical and its innovative solutions by visiting their official website.